InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Kasenchak Priscilla. Director active across 2 companies, notably agilon health, inc.. Cumulatively, 4 disclosures have been recorded. History available since 3 October 2022. The latest transaction was filed on 15 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations